Sjogren’s is not a simple disease. Nearly 40% of patients develop organ involvement, and the risk of lymphoma is 15 to 20 times that of the general population. It’s also a disease that’s often oversimplified as "just dryness"—even by rheumatologists.
Over the course of five groundbreaking episodes, you’ll hear from the world’s leading Sjogren’s experts, who will decode what every clinician needs to know: what Sjogren’s really looks like, what’s routinely being missed, and why over the next couple of years, everything is going to change.
This content is intended for medical professionals only.
All content for Decoding Sjogren’s Disease: A Clinical Deep Dive is the property of Health Monitor Network and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Sjogren’s is not a simple disease. Nearly 40% of patients develop organ involvement, and the risk of lymphoma is 15 to 20 times that of the general population. It’s also a disease that’s often oversimplified as "just dryness"—even by rheumatologists.
Over the course of five groundbreaking episodes, you’ll hear from the world’s leading Sjogren’s experts, who will decode what every clinician needs to know: what Sjogren’s really looks like, what’s routinely being missed, and why over the next couple of years, everything is going to change.
This content is intended for medical professionals only.
In our first episode, we tackle one of Sjogren’s most dangerous problems—diagnostic delay. We uncover why early recognition is critical to preventing irreversible organ damage and reducing lymphoma risk, and we break down the systemic blind spots that keep patients suffering for years before getting answers.
About Dr. Teja Kapoor
Dr. Kapoor is the Director of the Columbia Sjogren’s Center and a leading advocate for earlier recognition and systemic management of Sjogren’s disease.
In this episode, we explore:
(00:00) Sjogren's diagnostic challenges
(05:47) Sjogren's syndrome: lymphoma risk factors
(06:54) What clinicians tend to still get wrong about Sjogren's
(08:38) Clinical red flags and cues
(12:24) The additional systematic manifestations that may be overlooked
(13:22) If you take one thing from this episode...
Learn more about your ad choices. Visit podcastchoices.com/adchoices
Decoding Sjogren’s Disease: A Clinical Deep Dive
Sjogren’s is not a simple disease. Nearly 40% of patients develop organ involvement, and the risk of lymphoma is 15 to 20 times that of the general population. It’s also a disease that’s often oversimplified as "just dryness"—even by rheumatologists.
Over the course of five groundbreaking episodes, you’ll hear from the world’s leading Sjogren’s experts, who will decode what every clinician needs to know: what Sjogren’s really looks like, what’s routinely being missed, and why over the next couple of years, everything is going to change.
This content is intended for medical professionals only.
